Medicare Advantage in 2026: A $25 Billion Boost and What It Means for Providers

The healthcare landscape is rarely static, and for Medicare Advantage (MA) insurers, 2026 promises to be a pivotal year. The Centers for Medicare and Medicaid Services (CMS) recently announced a 5.06% payment increase for MA plans, translating to over $25 billion in additional funding. This bump, detailed in the 2026 Medicare Advantage Part C and Part D Payment Policies, exceeds the anticipated 4.3% outlined in the Advance Notice—a welcome surprise for an industry navigating turbulent financial waters. For providers—hospitals, clinics, and physician groups—this shift carries both immediate relief and long-term implications. Let’s unpack what’s driving this change, why it matters, and how providers can position themselves to thrive. 

A Lifeline After Lean Years 

The past few years have been bruising for MA insurers. High medical utilization, driven by an aging population and pent-up demand post-pandemic, has squeezed margins. Add to that declining star ratings—resulting in fewer bonus payments—and a prior year’s payment cuts, and it’s clear why this 5% increase feels like a lifeline. CMS projects this boost will inject stability into a program serving millions of seniors, reversing a trend of plan closures, rising premiums, and trimmed benefits. 

For providers, this is more than an insurer windfall—it’s a signal of resilience. MA plans, which now cover over half of Medicare-eligible beneficiaries, are a critical partner in care delivery. When insurers struggle, providers feel the ripple effects: narrower networks, delayed reimbursements, or pressure to cut costs. A $25 billion infusion could ease those tensions, offering breathing room to maintain robust provider networks and invest in patient care. 

Breaking Down the Numbers 

What’s behind this 5% uptick? CMS points to several factors. The effective growth rate for 2026, pegged at 9.04% (up from 5.93% in the Advance Notice), reflects updated per capita cost estimates from Medicare fee-for-service data, as calculated by the Office of the Actuary. This growth in benchmarks drives much of the payment increase. A technical adjustment to medical education costs—fully phased in at 100% for 2026—further bolsters the figure. Meanwhile, risk scores are set to rise by 2.1%, fueled by coding trends that better capture patient complexity. 

Star ratings bonuses, however, remain flat at -0.69%, a sore spot for insurers hoping for a lift. CMS is tweaking the ratings program, aligning it with the Universal Foundation quality measures and refining disaster adjustment criteria. For providers, this stasis underscores an ongoing challenge: quality metrics matter, but the rewards aren’t scaling with costs. 

Risk Adjustment: A Transition in Motion 

One of the most significant updates for 2026 is CMS’s overhaul of risk adjustment models. For non-PACE (Program of All-Inclusive Care for the Elderly) MA organizations, the three-year phase-in of the 2024 CMS-HCC model is complete—risk scores are now fully calculated using this updated framework. For PACE organizations, the transition is more gradual. CMS is blending 10% of the 2024 CMS-HCC model with 90% of the 2017 model for 2026, easing PACE providers into encounter data submissions via the Encounter Data System (EDS) rather than the older Risk Adjustment Processing System (RAPS). 

Why does this matter to providers? Risk adjustment drives reimbursement accuracy. A fully implemented 2024 model for MA plans could mean fairer payments for treating complex patients—think chronic conditions like diabetes or heart disease, common in the MA population. For PACE providers, the blended approach offers a buffer, reducing data submission burdens while aligning with broader MA standards. Accurate risk scores benefit everyone: insurers get funded appropriately, and providers see reimbursements that reflect patient needs. 

Why This Matters to Providers 

For healthcare providers, the $25 billion question is: how does this trickle down? Here’s the value proposition: 

1. Network Stability 
   Financially strained MA plans have been pruning networks, leaving some providers out in the cold. This payment boost could halt that trend, preserving partnerships and ensuring patients retain access to their preferred doctors and facilities. 

2. Investment in Care Delivery 
   With extra funds, insurers might prioritize innovations like telehealth expansion, chronic care management, or preventive services—areas where providers play a starring role. Expect more contracts or incentives tied to value-based care. 

3. Relief from Utilization Pressures 
   High utilization has been a double-edged sword: more patient visits mean more revenue, but also more strain on resources. Stabilized MA plans could ease reimbursement delays, helping providers manage cash flow and staffing. 

4. A Push for Quality 
   Flat star ratings bonuses signal that quality remains a sticking point. Providers tied to high-performing plans—or those willing to boost outcomes—could see a competitive edge. CMS’s focus on clinical care and patient experience in ratings updates is a nudge to prioritize what matters most. 

Opportunities and Challenges Ahead 

This payment increase isn’t a cure-all. Insurers and providers alike face a healthcare ecosystem in flux. Rising costs—driven by inflation, workforce shortages, and advanced treatments—won’t vanish overnight. The 5% bump outpaces inflation (hovering around 3% in recent projections), but it’s not a blank check. Providers must still navigate tight margins and evolving regulations. 

Yet the opportunities are tangible. A stabilized MA market could spark a renaissance in care models. Telehealth, already a lifeline for rural patients, might see renewed investment. Preventive programs, often sidelined during lean times, could rebound, reducing downstream costs. And as risk adjustment refines, providers adept at coding and documentation stand to gain—accuracy pays, literally. 

The challenge? Execution. Insurers must channel this $25 billion wisely, and providers need to align with their priorities. Collaboration is key—open dialogues about network needs, quality goals, and patient outcomes can turn this windfall into a win-win. 

The Bigger Picture 

Zoom out, and this announcement reflects broader trends. Medicare Advantage isn’t just growing—it’s reshaping healthcare delivery. With over 30 million enrollees and counting, MA plans are a juggernaut, blending private innovation with public funding. The 2026 rate increase signals CMS’s commitment to keeping this engine running, even amid political and economic shifts. As Mary Beth Donahue of the Better Medicare Alliance noted, “This payment rate will provide stability for millions of beneficiaries.” For providers, it’s a chance to ride the wave rather than be swept under. 

What Providers Can Do Now 

So how do you capitalize on this? Start with data. Review your MA patient mix—how well are you coding their conditions? A 2.1% risk score bump rewards precision. Next, strengthen ties with MA plans. A $25 billion pool means room for negotiation—push for fair rates or value-based contracts. Finally, double down on quality. Star ratings may not have budged, but patient satisfaction and outcomes still drive long-term success. 

A Turning Point 

The 2026 MA payment increase isn’t just a number—it’s a turning point. For providers, it’s a chance to reset after years of headwinds, to build stronger partnerships, and to deliver care that keeps pace with a changing world. The $25 billion infusion is a vote of confidence in Medicare Advantage, and by extension, in the providers who make it work. Let’s seize it.